Poirier D - Search Results

1

Complete inhibition of poly(ADP-ribose) polymerase activity prevents the recovery of C3H10T1/2 cells from oxidative stress.

Shah GM, Poirier D, Desnoyers S, Saint-Martin S, Hoflack JC, Rong P, ApSimon M, Kirkland JB, Poirier GG. Shah GM, et al. Among authors: poirier d, poirier gg. Biochim Biophys Acta. 1996 Jun 5;1312(1):1-7. doi: 10.1016/0167-4889(96)00004-3. Biochim Biophys Acta. 1996. PMID: 8679711 Free article.

2

Stimulation of poly(ADP-ribose) synthesis by free radicals in C3H10T1/2 cells: relationship with NAD metabolism and DNA breakage.

Lautier D, Poirier D, Boudreau A, Alaoui Jamali MA, Castonguay A, Poirier G. Lautier D, et al. Among authors: poirier d, poirier g. Biochem Cell Biol. 1990 Mar;68(3):602-8. doi: 10.1139/o90-085. Biochem Cell Biol. 1990. PMID: 2165410

3

Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo.

Shah GM, Poirier D, Duchaine C, Brochu G, Desnoyers S, Lagueux J, Verreault A, Hoflack JC, Kirkland JB, Poirier GG. Shah GM, et al. Among authors: poirier d, poirier gg. Anal Biochem. 1995 May 1;227(1):1-13. doi: 10.1006/abio.1995.1245. Anal Biochem. 1995. PMID: 7668367 Review. No abstract available.

4

The role of poly(ADP-ribose) metabolism in response to active oxygen cytotoxicity.

Lautier D, Hoflack JC, Kirkland JB, Poirier D, Poirier GG. Lautier D, et al. Among authors: poirier d, poirier gg. Biochim Biophys Acta. 1994 Apr 28;1221(3):215-20. doi: 10.1016/0167-4889(94)90243-7. Biochim Biophys Acta. 1994. PMID: 8167142

5

A novel aminosteroid of the 5α-androstane-3α,17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.

Jegham H, Roy J, Maltais R, Desnoyers S, Poirier D. Jegham H, et al. Among authors: poirier d. Invest New Drugs. 2012 Feb;30(1):176-85. doi: 10.1007/s10637-010-9548-6. Epub 2010 Oct 2. Invest New Drugs. 2012. PMID: 20890632

6

17 alpha-alkyl- or 17 alpha-substituted benzyl-17 beta-estradiols: a new family of estrone-sulfatase inhibitors.

Poirier D, Boivin RP. Poirier D, et al. Bioorg Med Chem Lett. 1998 Jul 21;8(14):1891-6. doi: 10.1016/s0960-894x(98)00330-8. Bioorg Med Chem Lett. 1998. PMID: 9873454

7

Overview of a rational approach to design type I 17beta-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: chemical synthesis and biological evaluation.

Tremblay MR, Poirier D. Tremblay MR, et al. Among authors: poirier d. J Steroid Biochem Mol Biol. 1998 Aug;66(4):179-91. doi: 10.1016/s0960-0760(98)00043-0. J Steroid Biochem Mol Biol. 1998. PMID: 9744515

8

Androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase.

Ngatcha BT, Luu-The V, Poirier D. Ngatcha BT, et al. Among authors: poirier d. Bioorg Med Chem Lett. 2000 Nov 20;10(22):2533-6. doi: 10.1016/s0960-894x(00)00517-5. Bioorg Med Chem Lett. 2000. PMID: 11086723

9

Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.

Boivin RP, Luu-The V, Lachance R, Labrie F, Poirier D. Boivin RP, et al. Among authors: poirier d. J Med Chem. 2000 Nov 16;43(23):4465-78. doi: 10.1021/jm0001166. J Med Chem. 2000. PMID: 11087571

10

Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase.

Poirier D, Boivin RP, Tremblay MR, Bérubé M, Qiu W, Lin SX. Poirier D, et al. J Med Chem. 2005 Dec 29;48(26):8134-47. doi: 10.1021/jm058235e. J Med Chem. 2005. PMID: 16366595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

264 results

Search Page